News
- Implementation strategy ich guideline m12 drug interaction studies (12/2024)
- Regulatory Science Research Needs update by European Medicine Agency (11/2024)
- Guideline on quality and equivalence of locally applied locally acting cutaneous products (11/2024)
- Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products (10/2024)
- Will Non-Animal Approaches Replace Some or All of Animal Testing? (03/2025)
- Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment (04/2025)
- FDA Admin Compliance Program Bioresearch monitoring (non clinical labs)(05/2025)
- FDA Road map to reducing animal testing in Preclinical Safety Studies (05/2025)
- FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs (05/2025)